Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Illumina, Inc. (ILMN)
since 2005 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Illumina, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1110803.
Total stock buying since 2005: $2,748,194.
Total stock sales since 2005: $1,191,574,365.
Total stock option exercises since 2005: $187,225,090.
Table 3. Detailed insider trading at Illumina, Inc. (ILMN)
Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
2025-05-13 | Thaysen Jacob (Chief Executive Officer) | Buy | 5,850 | 81.51 | 476,815 |
2025-05-12 | Dhingra Ankur (SVP, Chief Financial Officer) | Buy | 6,100 | 81.21 | 495,380 |
2025-05-12 | Thaysen Jacob (Chief Executive Officer) | Buy | 6,500 | 81.20 | 527,832 |
2024-02-22 | Thaysen Jacob (Chief Executive Officer) | Buy | 7,330 | 135.93 | 996,344 |
2023-11-07 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 315 | 112.84 | 35,544 |
2023-08-22 | Tousi Susan H (SVP, Chief Commercial Officer) | Sale | 500 | 167.04 | 83,520 |
2023-07-24 | Tousi Susan H (SVP, Chief Commercial Officer) | Sale | 500 | 190.08 | 95,040 |
2023-06-22 | Tousi Susan H (SVP, Chief Commercial Officer) | Sale | 500 | 200.00 | 100,000 |
2023-05-25 | Epstein Robert S (Director) | Option Ex | 7,600 | 71.09 | 540,284 |
2023-03-01 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 3,917 | 199.06 | 779,737 |
2023-02-22 | Aravanis Alexander (SVP, Chief Technology Officer) | Sale | 5,398 | 201.79 | 1,089,262 |
2023-02-21 | Pegels Kevin Carl (Chief of Global Operations) | Option Ex | 1,097 | .00 | 0 |
2023-02-21 | Reeves Kathryne Gambrell (SVP, Chief Marketing Officer) | Option Ex | 2,789 | .00 | 0 |
2023-02-21 | Aravanis Alexander (SVP, Chief Technology Officer) | Option Ex | 9,292 | .00 | 0 |
2023-02-21 | Tousi Susan H (SVP, Chief Commercial Officer) | Option Ex | 5,869 | .00 | 0 |
2023-02-21 | Hoyt Aimee L (SVP, Chief People Officer) | Option Ex | 5,282 | .00 | 0 |
2023-02-21 | Febbo Phillip G. (SVP Chief Medical Officer) | Option Ex | 3,522 | .00 | 0 |
2023-02-21 | Dadswell Charles (SVP & General Counsel) | Option Ex | 5,282 | .00 | 0 |
2023-02-21 | Goswami Joydeep (SVP Chief Financial Officer) | Option Ex | 4,696 | .00 | 0 |
2023-02-21 | Desouza Francis A (President and CEO) | Option Ex | 23,473 | .00 | 0 |
2023-02-06 | Tousi Susan H (SVP, Chief Commercial Officer) | Sale | 500 | 211.57 | 105,785 |
2022-07-07 | Aravanis Alexander (SVP, Chief Technology Officer) | Sale | 539 | 200.00 | 107,800 |
2022-06-10 | Tousi Susan H (SVP, Chief Commercial Officer) | Sale | 250 | 214.85 | 53,712 |
2022-04-28 | Dadswell Charles (SVP & General Counsel) | Sale | 368 | 300.13 | 110,447 |
2022-04-12 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 2,474 | 347.54 | 859,821 |
2022-04-06 | Febbo Phillip G. (SVP Chief Medical Officer) | Sale | 1,988 | 360.01 | 715,699 |
2022-03-28 | Dadswell Charles (SVP & General Counsel) | Sale | 368 | 342.83 | 126,161 |
2022-02-22 | Pegels Kevin Carl (Chief of Global Operations) | Option Ex | 1,065 | .00 | 0 |
2022-02-22 | Tousi Susan H (SVP, Chief Commercial Officer) | Option Ex | 4,561 | .00 | 0 |
2022-02-22 | Samad Sam (SVP and CFO) | Option Ex | 4,561 | .00 | 0 |
2022-02-22 | Dadswell Charles (SVP & General Counsel) | Option Ex | 4,561 | .00 | 0 |
2022-02-22 | Goswami Joydeep (SVP Corp Business Development) | Option Ex | 3,979 | .00 | 0 |
2022-02-22 | Desouza Francis A (President and CEO) | Option Ex | 19,383 | .00 | 0 |
2022-01-12 | Tousi Susan H (SVP, Chief Commercial Officer) | Sale | 800 | 425.00 | 340,000 |
2021-12-28 | Tousi Susan H (SVP, Chief Commercial Officer) | Sale | 100 | 387.06 | 38,706 |
2021-12-22 | Dadswell Charles (SVP & General Counsel) | Sale | 322 | 380.29 | 122,453 |
2021-12-08 | Tousi Susan H (SVP, Chief Commercial Officer) | Sale | 100 | 375.00 | 37,500 |
2021-11-22 | Dadswell Charles (SVP, General Counsel) | Sale | 314 | 377.86 | 118,648 |
2021-11-12 | Aravanis Alexander (SVP, Chief Technology Officer) | Sale | 361 | 386.35 | 139,472 |
2021-11-08 | Febbo Phillip G. (SVP Chief Medical Officer) | Sale | 1,000 | 406.83 | 406,830 |
2021-11-02 | Aravanis Alexander (SVP, Chief Technology Officer) | Sale | 2,926 | 412.96 | 1,208,318 |
2021-10-28 | Tousi Susan H (SVP, Chief Commercial Officer) | Sale | 100 | 414.35 | 41,435 |
2021-10-26 | Aravanis Alexander (SVP, Chief Technology Officer) | Sale | 2,926 | 423.00 | 1,237,698 |
2021-10-22 | Dadswell Charles (SVP & General Counsel) | Sale | 314 | 411.00 | 129,054 |
2021-10-19 | Aravanis Alexander (SVP, Chief Technology Officer) | Sale | 2,926 | 412.46 | 1,206,857 |
2021-10-12 | Aravanis Alexander (SVP, Chief Technology Officer) | Sale | 2,926 | 409.37 | 1,197,810 |
2021-09-28 | Tousi Susan H (SVP, Chief Commercial Officer) | Sale | 100 | 418.04 | 41,804 |
2021-09-22 | Dadswell Charles (SVP & General Counsel) | Sale | 314 | 436.69 | 137,120 |
2021-08-30 | Tousi Susan H (SVP, Chief Commercial Officer) | Sale | 300 | 463.50 | 139,050 |
2021-08-23 | Dadswell Charles (SVP & General Counsel) | Sale | 314 | 489.10 | 153,577 |
2021-08-04 | Tousi Susan H (SVP, Chief Commercial Officer) | Sale | 1,000 | 500.00 | 500,000 |
2021-08-04 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 372 | 500.00 | 186,000 |
2021-07-28 | Tousi Susan H (SVP, Chief Commercial Officer) | Sale | 300 | 486.41 | 145,923 |
2021-07-22 | Dadswell Charles (SVP & General Counsel) | Sale | 314 | 482.23 | 151,420 |
2021-07-07 | Aravanis Alexander (SVP, Chief Technology Officer) | Sale | 539 | 477.59 | 257,421 |
2021-06-28 | Tousi Susan H (SVP, Chief Commercial Officer) | Sale | 300 | 478.95 | 143,685 |
2021-06-24 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 500 | 475.00 | 237,500 |
2021-06-11 | Febbo Phillip G. (SVP Chief Medical Officer) | Sale | 1,000 | 447.61 | 447,613 |
2021-06-10 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 500 | 450.00 | 225,000 |
2021-06-10 | Dorsa Caroline (Director) | Sale | 1,000 | 450.00 | 450,000 |
2021-05-18 | Flatley Jay T (Director) | Sale | 4,000 | 379.53 | 1,518,120 |
2021-05-05 | Tousi Susan H (SVP Product Development) | Sale | 300 | 381.88 | 114,564 |
2021-05-04 | Flatley Jay T (Director) | Sale | 4,000 | 384.15 | 1,536,600 |
2021-04-22 | Dadswell Charles (SVP & General Counsel) | Sale | 314 | 402.02 | 126,234 |
2021-04-20 | Flatley Jay T (Director) | Sale | 4,000 | 401.83 | 1,607,320 |
2021-04-06 | Tousi Susan H (SVP Product Development) | Sale | 500 | 423.44 | 211,717 |
2021-04-06 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 1,000 | 424.22 | 424,218 |
2021-04-06 | Flatley Jay T (Director) | Sale | 4,000 | 423.44 | 1,693,740 |
2021-04-05 | Tousi Susan H (SVP Product Development) | Sale | 300 | 386.03 | 115,808 |
2021-04-05 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 1,000 | 386.03 | 386,030 |
2021-03-22 | Dadswell Charles (SVP & General Counsel) | Sale | 314 | 416.24 | 130,699 |
2021-03-16 | Flatley Jay T (Director) | Sale | 4,000 | 421.06 | 1,684,240 |
2021-03-05 | Tousi Susan H (SVP Product Development) | Sale | 800 | 402.24 | 321,792 |
2021-03-02 | Flatley Jay T (Director) | Sale | 4,000 | 444.61 | 1,778,440 |
2021-02-18 | Mcginnis Karen K (VP, Chief Accounting Officer) | Sale | 666 | 486.75 | 324,175 |
2021-02-17 | Tousi Susan H (SVP Product Development) | Option Ex | 6,306 | .00 | 0 |
2021-02-17 | Hoyt Aimee L (SVP, Chief People Officer) | Option Ex | 4,625 | .00 | 0 |
2021-02-17 | Samad Sam (SVP and CFO) | Option Ex | 4,379 | .00 | 0 |
2021-02-17 | Febbo Phillip G. (SVP Chief Medical Officer) | Option Ex | 3,173 | .00 | 0 |
2021-02-17 | Dadswell Charles (SVP & General Counsel) | Option Ex | 3,503 | .00 | 0 |
2021-02-17 | Desouza Francis A (President and CEO) | Option Ex | 24,521 | .00 | 0 |
2021-02-17 | Ragusa Robert P (SVP, Global Quality & Ops) | Option Ex | 6,306 | .00 | 0 |
2021-02-17 | Mcginnis Karen K (VP, Chief Accounting Officer) | Option Ex | 935 | .00 | 0 |
2021-02-16 | Flatley Jay T (Director) | Sale | 4,500 | 498.48 | 2,243,146 |
2021-02-05 | Tousi Susan H (SVP Product Development) | Sale | 800 | 431.90 | 345,520 |
2021-02-02 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 57 | 444.84 | 25,355 |
2021-02-02 | Flatley Jay T (Director) | Sale | 4,000 | 444.84 | 1,779,360 |
2021-02-02 | Mcginnis Karen K (VP, Chief Accounting Officer) | Sale | 72 | 444.84 | 32,028 |
2021-02-01 | Desouza Francis A (President and CEO) | Sale | 3,000 | 439.46 | 1,318,368 |
2021-01-20 | Tousi Susan H (SVP Product Development) | Sale | 2,500 | 400.00 | 1,000,000 |
2021-01-19 | Flatley Jay T (Director) | Sale | 4,000 | 382.48 | 1,529,920 |
2021-01-11 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 271 | 379.65 | 102,885 |
2021-01-05 | Tousi Susan H (SVP Product Development) | Sale | 300 | 365.27 | 109,581 |
2021-01-05 | Flatley Jay T (Director) | Sale | 4,000 | 365.27 | 1,461,080 |
2021-01-04 | Desouza Francis A (President and CEO) | Sale | 3,000 | 370.51 | 1,111,533 |
2020-12-15 | Flatley Jay T (Director) | Sale | 4,000 | 348.84 | 1,395,360 |
2020-12-14 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 354 | 345.00 | 122,130 |
2020-12-10 | Ronaghi Mostafa (SVP, Entrepreneurial Devlopmt) | Sale | 5,000 | 338.83 | 1,694,175 |
2020-12-07 | Tousi Susan H (SVP Product Development) | Sale | 300 | 349.01 | 104,704 |
2020-12-04 | Tousi Susan H (SVP Product Development) | Sale | 200 | 350.00 | 70,000 |
2020-12-01 | Tousi Susan H (SVP Product Development) | Sale | 100 | 325.00 | 32,500 |
2020-12-01 | Dadswell Charles (SVP & General Counsel) | Sale | 1,694 | 323.86 | 548,618 |
2020-12-01 | Desouza Francis A (President and CEO) | Sale | 3,000 | 328.50 | 985,509 |
2020-12-01 | Flatley Jay T (Director) | Sale | 4,000 | 323.94 | 1,295,740 |
2020-11-30 | Ragusa Robert P (SVP, Global Quality & Ops) | Sale | 2,890 | 315.39 | 911,465 |
2020-11-18 | Mcginnis Karen K (VP, Chief Accounting Officer) | Sale | 218 | 300.00 | 65,400 |
2020-11-17 | Flatley Jay T (Director) | Sale | 3,000 | 297.37 | 892,110 |
2020-11-06 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 215 | 310.10 | 66,671 |
2020-11-06 | Febbo Phillip G. (SVP Chief Medical Officer) | Sale | 155 | 310.10 | 48,065 |
2020-11-06 | Mcginnis Karen K (VP, Chief Accounting Officer) | Sale | 312 | 310.10 | 96,751 |
2020-11-03 | Flatley Jay T (Director) | Sale | 3,000 | 297.50 | 892,515 |
2020-11-02 | Dadswell Charles (SVP & General Counsel) | Sale | 121 | 298.00 | 36,058 |
2020-11-02 | Desouza Francis A (President and CEO) | Sale | 3,000 | 300.05 | 900,156 |
2020-10-20 | Flatley Jay T (Director) | Sale | 4,000 | 322.48 | 1,289,920 |
2020-10-12 | Tousi Susan H (SVP Product Development) | Sale | 200 | 350.00 | 70,000 |
2020-10-07 | Tousi Susan H (SVP Product Development) | Sale | 100 | 325.00 | 32,500 |
2020-10-07 | Flatley Jay T (Director) | Sale | 1,000 | 324.01 | 324,010 |
2020-10-06 | Flatley Jay T (Director) | Sale | 3,000 | 317.79 | 953,370 |
2020-10-01 | Dadswell Charles (SVP & General Counsel) | Sale | 121 | 312.82 | 37,851 |
2020-10-01 | Desouza Francis A (President and CEO) | Sale | 3,000 | 309.80 | 929,396 |
2020-09-15 | Flatley Jay T (Director) | Sale | 4,000 | 355.22 | 1,420,880 |
2020-09-09 | Tousi Susan H (SVP Product Development) | Sale | 200 | 350.00 | 70,000 |
2020-09-08 | Tousi Susan H (SVP Product Development) | Sale | 100 | 336.00 | 33,600 |
2020-09-01 | Van Oene Mark (SVP Chief Commercial Officer) | Sale | 625 | 355.71 | 222,320 |
2020-09-01 | Dadswell Charles (SVP & General Counsel) | Sale | 1,687 | 355.35 | 599,475 |
2020-09-01 | Desouza Francis A (President and CEO) | Sale | 3,000 | 352.51 | 1,057,524 |
2020-09-01 | Flatley Jay T (Director) | Sale | 4,000 | 355.35 | 1,421,400 |
2020-08-31 | Ragusa Robert P (SVP, Global Quality & Ops) | Sale | 5,000 | 355.19 | 1,775,954 |
2020-08-18 | Flatley Jay T (Director) | Sale | 4,000 | 354.03 | 1,416,120 |
2020-08-10 | Mcginnis Karen K (VP, Chief Accounting Officer) | Sale | 1,856 | 357.01 | 662,610 |
2020-08-05 | Tousi Susan H (SVP Product Development) | Sale | 800 | 398.70 | 318,960 |
2020-08-04 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 29 | 397.73 | 11,534 |
2020-08-04 | Flatley Jay T (Director) | Sale | 4,000 | 397.73 | 1,590,920 |
2020-08-03 | Van Oene Mark (SVP Chief Commercial Officer) | Sale | 625 | 385.43 | 240,893 |
2020-08-03 | Dadswell Charles (SVP & General Counsel) | Sale | 121 | 385.19 | 46,607 |
2020-08-03 | Desouza Francis A (President and CEO) | Sale | 3,000 | 389.73 | 1,169,187 |
2020-07-21 | Flatley Jay T (Director) | Sale | 4,000 | 399.00 | 1,596,000 |
2020-07-20 | Tousi Susan H (SVP Product Development) | Sale | 500 | 400.00 | 200,000 |
2020-07-07 | Flatley Jay T (Director) | Sale | 4,000 | 370.22 | 1,480,880 |
2020-07-01 | Van Oene Mark (SVP Chief Commercial Officer) | Sale | 625 | 368.84 | 230,524 |
2020-07-01 | Dadswell Charles (SVP & General Counsel) | Sale | 121 | 369.26 | 44,680 |
2020-07-01 | Desouza Francis A (President and CEO) | Sale | 3,000 | 366.11 | 1,098,339 |
2020-06-16 | Flatley Jay T (Director) | Sale | 4,000 | 354.93 | 1,419,720 |
2020-06-15 | Ragusa Robert P (SVP, Global Quality & Ops) | Sale | 5,000 | 340.52 | 1,702,625 |
2020-06-08 | Hoyt Aimee L (SVP, Chief People Officer) | Sale | 191 | 350.94 | 67,029 |
2020-06-02 | Flatley Jay T (Director) | Sale | 4,000 | 364.40 | 1,457,600 |
2020-06-01 | Van Oene Mark (SVP Chief Commercial Officer) | Sale | 625 | 361.75 | 226,095 |
2020-06-01 | Dadswell Charles (SVP & General Counsel) | Sale | 1,686 | 362.60 | 611,343 |
2020-06-01 | Desouza Francis A (President and CEO) | Sale | 3,000 | 362.10 | 1,086,303 |
2020-05-28 | Tousi Susan H (SVP Product Development) | Sale | 600 | 375.00 | 225,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
of ILMN listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Illumina, Inc. (symbol ILMN,
CIK number 1110803) see
the Securities and Exchange Commission (SEC) website.